Leenor Alfahel
Beersheba, D 84105, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Protocol for handling and using SOD1 mice for amyotrophic lateral sclerosis pre-clinical studies.
Journal: STAR protocols
Published: July 19, 2024
Translational challenges in amyotrophic lateral sclerosis therapy with macrophage migration inhibitory factor.
Journal: Neural regeneration research
Published: June 03, 2024
Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models.
Journal: Nature neuroscience
Published: December 14, 2023
CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis.
Journal: Journal of neuroinflammation
Published: November 05, 2023
Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Journal: Cell reports. Medicine
Published: May 17, 2023
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo.
Journal: Biomolecules
Published: December 25, 2022
4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice.
Journal: International journal of molecular sciences
Published: July 17, 2022
Early upregulation of cytosolic phospholipase A2α in motor neurons is induced by misfolded SOD1 in a mouse model of amyotrophic lateral sclerosis.
Journal: Journal of neuroinflammation
Published: April 01, 2021
Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Journal: Nature
Published: August 15, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026